The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Code | Title | |
|---|---|---|
| A02BD01 | Omeprazole, amoxicillin and metronidazole | |
| A02BD02 | Lansoprazole, tetracycline and metronidazole | |
| A02BD03 | Lansoprazole, amoxicillin and metronidazole | |
| A02BD04 | Pantoprazole, amoxicillin and clarithromycin | |
| A02BD05 | Omeprazole, amoxicillin and clarithromycin | |
| A02BD06 | Esomeprazole, amoxicillin and clarithromycin | |
| A02BD07 | ||
| A02BD08 | ||
| A02BD09 | ||
| A02BD10 | ||
| A02BD11 | ||
| A02BD12 | ||
| A02BD13 | ||
| A02BD14 | ||
| A02BD15 | ||
| A02BD16 | ||
| A02BD17 |
| Title | Information Source | Document Type | |
|---|---|---|---|
| PYLERA Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |